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ABSTRACT: The theory for measuring ligand binding constants from footprinting autoradiographic data
associated with a single binding site is derived. If the ligand and DNA cleavage agent compete for a common
site, the spot intensities are not proportional to the amount of D N A not blocked by ligand. The analysis
of a single site is experimentally illustrated by using results for the anticancer drug actinomycin D interacting
with the duplex d(TAGCGCTA)2 as probed with the hydrolytic enzyme DNase I.

F o o t printing analysis utilizes DNA sequencing methodology
to locate the binding sites of drugs and proteins on DNA
molecules of heterogeneous sequence (Galas & Schmitz, 1978;
Lane et al., 1983; Scamrov & Beabealashvili, 1983; Van Dyke
et ai., 1982). In the footprinting experiment, DNA which has
come to equilibrium with a ligand is allowed to interact with
a probe capable of cutting the DNA at various sites. From
the amounts of the different oligonucleotide fragments produced, one can infer where the ligand binds on the DNA,
assuming that ligand bound at a DNA site prevents the probe
from cleaving at that site. In quantitative footprinting studies,
'Supported by American Cancer Society Grant NP-681.
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the amounts of fragments produced in the digest are analyzed
to extract individual site binding isotherms and determine
ligand binding constants as a function of sequence. It has now
been demonstrated that one can obtain binding constants for
ligands on large DNA polymers as well as small oligomers
(Brenowitz et al., 1986; Carey, 1988; Dabrowiak & Goodisman, 1989; Goodisman & Dabrowiak, 1990; Ikeda & Richardson, 1986; Gunderson et al., 1987; Letovsky & Dynan,
1989; Fish et al., 1988; Brenowitz & Senear, 1989).
For an oligomer with only one binding site, the quantitative
analysis of footprinting data is quite simple, but not without
pitfalls. In the present paper, we show the correct method for
extracting the ligand-DNA binding constant from footprinting
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data for a single-site situation and point out how an apparently
sound treatment leads to anomalous results. It is sometimes
assumed that the measured autoradiographic spot intensities
within a ligand binding site are proportional to the fraction
of that site unoccupied by ligand but, as was recently pointed
out (Dabrowiak & Goodisman, 1989; Ward et al., 1988), this
is true only if the amount of DNA to which the cleavage agent
can bind is not significantly changed as ligand is added to the
system. For example, with the enzyme DNase I or the synthetic compound Fe-MPE, which cleave DNA with little or
no sequence specificity, the proportionality holds well (Ward
et al., 1988; Dabrowiak et al., 1989a). Since the ratio of
ligand-blocked DNA to unblocked DNA is small for large
restriction fragments, the effective concentration of the
cleavage agent or probe at a site does not significantly increase
as ligand is added. However, if the specificity of the cleavage
agent is high and is similar to the specificity of the ligand being
studied, the proportionality between spot intensity and fraction
of site unoccupied may not hold. This occurs for a case recently examined by us, in which the probe was the cationic
metalloporphyrin complex MnT4MPyP and the ligand the
antiviral agent netropsin, both of which compete for AT-rich
sites on DNA (Dabrowiak et al., 1989b).
In this report, we consider a small oligonucleotide duplex
possessing a single actinomycin binding site. In this case, in
which ligand and probe compete for a very limited amount
of DNA, the lack of proportionality between the autoradiographic spot intensity, on one hand, and 1 minus the occupancy
of the site by a drug molecule, on the other, has important
consequences We show that incorrectly assuming this proportionality can have a significant effect on the binding constants derived from footprinting data. This explains why the
binding constants recently reported from analysis of footprinting data for netropsin and distamycin bound to small
oligonucleotide duplexes are anomalously low (Fish et al.,
1988). We apply a correct analysis to footprinting data for
binding of actinomycin D on a small oligomer and derive the
binding constant for this drug.
EXPERIMENTAL
PROCEDURES
The self-complementary oligonucleotide d(TAGCGCTA)2
was synthesized on a Biosearch 8600 synthesizer and purified
by using a Waters Associates HPLC. The molar extinction
coefficient of the oligonucleotide was determined by measuring
the difference in optical absorbance of a sample at 259 nm
before and after exhaustive digestion with snake venom
phosphodiesterase (Sigma) in a buffer of 100 mM ammonium
acetate (pH 7.5). The molar extinction coefficient of the
mixture of mononucleotides was determined by using the expected molar ratios of the mononucleotides present and their
individual molar extinction coefficients. The value of tM found
for d(TAGCGCTA)2 was 1.58 X lo5 M-’ cm-’. Actinomycin
D concentrations were measured optically with a value of t M
of 24400 M-I cm-’ at 440 nm.
The oligonucleotide was labeled at its 5’ end using [ y 32P]ATP/polynucleotidekinase and purified via electrophoresis
in a 25% polyacrylamide gel containing 6 M urea (Maniatis
et al., 1982). The DNase I footprinting reactions were carried
out in a total volume of 8 pL, for 10 min at 25 OC, in a buffer
consisting of 10 mM Tris (pH 7.5), 8 mM MgC12, and 2 mM
CaCl,. Thirteen different final drug concentrations between
1 and 12 pM, associated with two separate footprinting titrations, were preincubated with the DNA prior to the addition
of the enzyme. The final concentration of DNA present in
all experiments was 24.3 pM in base pairs (3.04 pM in duplex)
while the enzyme concentration was about 0.2 pM. After the

reaction was quenched by the addition of urea, the oligonucleotide products were loaded into a 25% polyacrylamide
gel and separated via electrophoresis. The resulting autoradiograms were scanned to yield band areas proportional to
concentrations. The intensities derived from three of the
cleavage products were used in the analysis in the drug concentration range 1-4 pM.

SINGLE-SITE
MODEL
Since DNase I must bind to DNA in order to cleave it, the
rate at which cleavage occurs at a particular site i is proportional to up, the probability that an enzyme molecule is
bound at that site, or the fraction of sites i having an enzyme
molecule bound. If the enzyme digest is allowed to proceed
only until about 30% of the DNA is cleaved (the “single-hit”
regime), the number of oligonucleotide fragments due to
cleavage at i is proportional to the initial cleavage rate. The
spot intensity or band area on the autoradiogram corresponding
to cleavage at site i, I,, is proportional to the concentration of
the corresponding fragment produced, i.e.

Ii = kiup

(1)

with ki a constant. If the ratio of the ligand-blocked DNA
to unblocked DNA is small, the quantity up is proportional to
pi, the probability that site i is not blocked to the enzyme, and
to the concentration of enzyme at the site, which will be determined by the fraction of sites available to the enzyme.
Then, in eq 1, one can put k,qDNase I]p, for k,up (ki’ a
constant), as in previous work (Ward et al., 1988). In the
present, single-site, case, we calculate up by considering a
competitive binding equilibrium between the ligand and the
probe.
Because the binding constant for the ligand will be higher
than that for the probe, a ligand molecule binding at a site
will generally displace a probe molecule. If enough probe is
available to saturate the site in the absence of ligand (vp N
l), up in the presence of ligand will indeed be equal to p i or
1 - ui,where vi is the fraction of binding site occupied by ligand.
However, in general, up will be only approximately proportional
to 1 - uir and, as we show below, small deviations from the
proportionality of the amount of cleavage product to 1 - vi can
be very important and lead to major errors in equilibrium
binding constants derived from footprinting data.
We consider a DNA oligomer, with one site which may be
occupied either by the ligand or by the probe, i.e., simultaneous
occupancy is not possible. Let c be the concentration of oligomer, P,the total concentration of probe, and D,the total
concentration of ligand. It should be noted that one generally
knows D,,whereas it is the concentration of free ligand which
enters the binding constant expressions. Since there is only
one site per oligomer, we suppress the site index i, so that I
represents the autoradiographic spot intensity (proportional
to the concentration of cleavage product produced in the digest) and t$, represents the fraction of site occupied by ligand.
The “footprinting plot” is I as a function of D,(Ward et al.,
1988; Dabrowiak & Goodisman, 1989).
According to eq 1, I will be proportional to up, where vb and
vp are determined by the equilibrium expressions:
K =

Kp=

cub

( c - cub

- Cvp)(Dt

- cub)

CUP

(c

- cvb - cvp)(P, - cup)

(2)
(3)

Here, K is the binding constant for ligand to the site and Kp
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FIGURE 2: Desitometric scan of autoradiographic data of DNase I
cleavage of d(TAGCGCTA)2 is shown. The cleavage products
represented by peaks 2-4 were used in the analysis. Peak 1 is the
uncleaved oligomer.

FIGURE 1 :

the binding constant of the probe to the same site. The object
of the analysis of footprinting data is the determination of K:
we expect that, for this and similar systems, K >> Kp’ In the
absence of ligand (0,
= t+, = 0), up becomes vpo; eq 3 gives

P, + c + K;’
up0

=

- d ( P t + c + KL1)2- ~ c P ,
7”
LL

Let Io be the value of I in the absence of ligand; Io is proportional to upo.
In the presence of ligand, eqs 2 and 3 must be solved simultaneously. One obtains a cubic equation for up, which may
be written
[U;C

- up(Pt+ c + K;’)

+ P,][up~(K- Kp) + K$,] +
u,K(u,c - PJK, = 0 (4)

Given values for K and Kp, eq 4 may be solved numerically
for any desired values of c, P,,and 0,. Then Illo = up/upo.
The data one generally has to analyze consist of experimental
values of I , which are proportional to the amount of oligonucleotide produced in the digest, as a function of D,, with c
and P,constant. Our procedure (Dabrowiak et al., 1989b)
is to seek the values of K and Kp which give calculated I as
a function of D,in closest possible agreement with experiment.
The quantity 1 - I/Io is sometimes referred to as the “degree
of protection”. If one assumes that the degree of protection
is equal to Yb, one can calculate the free ligand concentration
as D, - c(l - Z/Zo) and write eq 2 as
1 - I/Io
K=
( I / l o ) [ D ,- 4 1 - I/IO)l
From a plot of I / I o as a function of D,, one can then easily
determine K. As we will now show, such a procedure can lead
to large errors because the actual free ligand concentration,
D,- Cub, can be very different from D,- c(1 - Z/Zo).
We first show calculated results, based on eq 4, using the
experimental parameters c = 8.85 pM, P, = 1 pM, and D,
between 0 and 200 pM (Fish et al., 1988). We assume K =
IO7 M-’ and Kp = 5 X lo4 M-I. We calculate up, and Illo
= up/upo [upo is small here (0.0338) because the binding constant Kp is small]. The degree of protection,f= 1 - Z/Zo, starts
at 0 for D, = 0. As D,increases,frises, at first almost linearly
with D,, and then levels off as the ratio of D,to c approaches
unity.
In the inset of Figure 1, Vb is plotted against 1 - Z/Zo. The
deviation of this curve from a line of unit slope shows the error
in assuming that vb is equal to$ Although the deviation does
not appear large, it in fact leads to enormous errors in the
determination of the ligand binding constant. For an equi-

librium like eq 2, one often determines K experimentally by
plotting measured values of vb against x, the negative logarithm
of the free ligand concentration (Bjerrum plot). The value
of x for which ub =
should be log K. In Figure 1 , f i s
plotted against x. For the right-hand plot (points represented
by squares), which resembles a Bjerrum plot, the correct free
ligand concentration is used, i.e., D, - vbc; for the left-hand
plot (circles), the apparent free ligand concentration, D,- fc,
is used.
The two plots are obviously quite different. The left-hand
plot does not have a shape like a Bjerrum plot, and the apparent value of K (from the value of x which makes ub = 1/2)
is close to lo6, which is an order of magnitude lower than the
true value. Even for the values of Kp and K used here, the
assumption f = Vb leads to very large errors in the free ligand
concentration. The correct value of K is obtained from the
right-hand plot, 1 - I/Zo vs -log (0,- Vbc). The value obtained
for log K is actually slightly below 7 because of the slight
difference between 1 - I/Zo and Vb, a difference which has a
large effect on the calculated free ligand concentration.
One should expect that, if one plotsf = 1 - I/Zo against the
negative logarithm of 0,-fc, the data may not fit a Bjerrum
plot, even if Kp is several orders of magnitude less than K.
Indeed, from such a plot, one can judge whether the assumptionf = ub is justified. If the shape of the plot is very
different from a Bjerrum plot [for example, the slope at vb =
should be (4 log e ) - ’ ] ,a more accurate analysis, such as
the following, is required to obtain K.
ACTINOMYCIN
D BINDINGTO D(TAGCGCTA),
DNase I cleavage of d(TAGCGCTA)* produces three major
oligonucleotide products, shown in Figure 2. When actinomycin D (Act-D) is added to the system, the amount of each
of the products decreases in the manner shown in Figure 3.
The fact that no enhancements are observed as drug is added
(Figure 3) shows that drug displaces enzyme from the duplex
and thus drug and enzyme compete for a common DNA site.
For this duplex, with two GC dimers, there are two equivalent
binding sites for actinomycin D. However, there is room to
bind only one drug molecule to the duplex, so that one bound
drug should exclude binding of a second drug or the enzyme.
Scott et al. (1988) reported that two actinomycin D molecules
can bind to the sequence 5’-GCGC-3’ but that the second drug
binds in an anticooperative manner with a binding constant
for the second drug a factor of 20 lower than that of the first
Act-D molecule. Since only the early part of the footprinting
titration was used in this analysis, a duplex possessing two
bound Act-D molecules was not part of our model.
We treat the situation as if there were two mutually exclusive binding sites, rather than a single site, and ligand
binding at either site blocked cleavage by DNase I. To take
into account the presence of two mutually exclusive binding
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FIGURE 3: Intensities of peaks 2-4 of Figure 2 as a function of
actinomycin D concentration. Footprinting plots, for two separate
experiments (A and B), are shown. Closed symbols are experimental
intensities while the open symbols are the calculated values using the
model described in the text.

sites, we have to modify eqs 2 and 3 slightly.
Let K,and K 2be the equilibrium constants for binding of
drug at the two sites and ul and u2 the fraction of oligomers
which have drug bound at the two sites. Then, analogously
to eq 2

K1 =

(C

- CUI

- CUZ

cv I
- C Y ~ ) (-DC U ~
I

- CY^)

(5)

and similarly for site 2. In eq 3, one has to substitute u1 +
u2 for ub Adding together eq 5 and the corresponding equation
for site 2, we have

Thus, we recover eq 2, except that now K represents K,+ K,
and u represents ul u2. The data can be analyzed as a
single-site problem, except that, if the two sites are equivalent
(K,= K 2 ) , the resulting equilibrium constant actually represents twice the actual site binding constant.
Two sets of footprinting data, each consisting of autoradiographic spot intensities for three cleaved fragments, were
analyzed to obtain the equilibrium binding constant of Act-D.
One drug binding site with binding constant K was assumed,
such that drug binding blocks the cutting events leading to the
three fragments. Thus, the equilibrium binding constant for
a single drug binding mode is K/2. The analysis involves
calculating V b as a function of drug concentration, assuming
particular values of the binding constants K and Kp, and
seeking the values of K and K pwhich give the minimum deviation between experimental and calculated data. For each
of the two footprinting titrations, the data for all three sites,
at all the concentrations shown, were used simultaneously, and
fit with the same values of K and K p .
In Figure 3, we show experimental and theoretical footprinting plots, the latter calculated with the values of K and
K pwhich minimize D, the deviation between experimental and
calculated data. The agreement between experiment and

+

theory is within the experimental error, as judged from the
scatter in the experimental points. From the first set of data
(Figure 3A), we find K = 7 X lo6 M-' and K p = 10 M-l; the
second set (Figure 3B) yields K = 9 X lo6 M-' and K p= 20
M-I. In Figure 4,we show, for the data of Figure 3A, D as
a function of K p with K fixed at 7 X lo6 M-l, and D as a
function of K with K p fixed at 10 M-I. These plots allow an
estimate of the precision of the determined equilibrium constants. The value of Kp,the binding constant of DNase I
toward DNA, is not accurately determined. However, it is
less than about lo4 M-I. The determined value of K is good
to about f 3 X lo6, since changing K by more than this leads
to an increase in D by 10%.
The Act-D binding constant toward a single site on the
8-mer derived in this study (-4 X lo6 M-I) is in good
agreement with the results of other binding studies using
classical techniques. For example, although the salt conditions
were not the same as those used in this study, the sequence
AGCT in d(ATAAGCTTAT)2 binds Act-D with a binding
constant of 5 X lo6 M-l (Chen, 1988). The binding constant
is somewhat sequence dependent. If the G C site is flanked
by C and G, as is the case for d(ATACGCGTAT),, the
binding constant exhibits a slight increase to 8 X 106 M-'. This
work confirms the utility of quantitative footprinting analysis
for obtaining binding constants of drugs to DNA.

CONCLUSIONS
In this paper, we analyze the footprinting experiment associated with a single site involving a competitive equilibrium
between the cleavage agent and a DNA binding ligand. In
this case, the lack of proportionality between the autoradiographic spot intensities and 1 minus the occupancy of the site
by the ligand has particularly marked consequences. Assuming
that the proportionality is valid can lead to measured binding
constants which are too low, as seems to have occurred for the
recently reported binding constants of netropsin and distamycin, which are significantly lower than those expected for
these drugs interacting with the duplex d(GGTATACC)2 (Fish
et al., 1988). The analysis presented also applies to proteinDNA footprinting experiments involving DNase I as well as
other chemical cleaving agents, e.g., Fe-MPE. If the ratio of
protein-blocked sites to free sites on DNA is small, the autoradiographic spot intensities associated with binding will be
nearly proportional to the amount of free DNA not blocked
by protein. This situation will arise if the fragment on which
binding is occurring is long or if it is short but additional
nonlabeled DNA is present in the system which can bind the
cleavage agent but not the protein. If the fragment is small,
the spot intensities will not be proportional to 1 minus the
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fraction of site bound by ligand, and care must be taken in
the analysis of the data.
Registry No. DNase 1,9003-98-9;d(TAGCGCTA),
115710-85-5;
actinomycin D, 50-76-0.
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ABSTRACT: The thermal dependence of the structural stability of membrane-reconstituted yeast cytochrome

c oxidase has been studied by using different techniques including high-sensitivity differential scanning
calorimetry, differential detergent solubility thermal gel analysis, and enzyme activity measurements. For
these studies, the enzyme has been reconstituted into dimyristoylphosphatidylcholine (DMPC) and dielaidoylphosphatidylcholine(DEPC) vesicles using detergent dialysis. The phospholipid moiety affects the
stability of the enzyme as judged by the dependence of the denaturation temperature on the lipid composition
of the bilayer. The enzyme is more stable when reconstituted with the 18-carbon, unsaturated phospholipid
(DEPC) than with the 14-carbon saturated phospholipid (DMPC). In addition, the shapes of the calorimetric
transition profiles are different in the two lipid systems, indicating that not all of the subunits are affected
equally by the lipid moiety. The overall enthalpy change for the enzyme denaturation is essentially the
same for the two lipid reconstitutions (405 kcal/mol of protein for the DMPC and 425 kcal/mol for the
DEPC-reconstituted enzyme). In both systems, the van? Hoff to calorimetric enthalpy ratios are less than
0.2,indicating that the unfolding of the enzyme cannot be represented as a two-state process. Differential
detergent solubility experiments have allowed us to determine individual subunit thermal denaturation profiles.
These experiments indicate that the major contributors to the main transition peak observed calorimetrically
are subunits I and I1 and that the transition temperature of subunit I11 is the most affected by the phospholipid
moiety. Experiments performed at different scanning rates indicate that the thermal denaturation of the
enzyme is a kinetically controlled process characterized by activation energies on the order of 40 kcal/mol.
These studies have allowed us to quantitatively model the thermal denaturation mechanism of the enzyme.

x e formation of functionally active integral membrane
protein assemblies involves membrane insertion, folding, and
subunit association of the constituent polypeptide units. The
molecular details and energetics of those processes are still not
'Supported by grants from the National Institues of Health (GM
3791 1 and RR 04328).
* To whom correspondence should be addressed.

completely understood. Cytochrome c oxidase is the terminal
enzyme of the respiratory chain, catalyzing the transfer of
electrons from cytochrome c to molecular oxygen while simultaneously serving as a proton pump. Cytochrome c oxidase
is a multisubunit enzyme composed of mitochondrially synthesized subunits and subunits imported from the cytoplasm.
In most species, the three largest subunits (I, 11, 111) are
synthesized in the mitochondria and the remaining subunits
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